So far, only three prospective cohort studies with relatively small cases numbers (patients with diabetes ranged from 54 to 123) have been conducted, and all reported a positive association between higher FGF-21 levels and increased risk of type 2 diabetes [6–8]. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.